Daniel Marini
Chief Operating Officer at ROBEX RESOURCES INC.
Net worth: - $ as of 2024-03-30
Daniel Marini active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ROBEX RESOURCES INC. | Chief Operating Officer | 2023-09-20 | - |
| Corporate Officer/Principal | 2023-05-31 | 2023-09-20 | |
EryPharm SAS
 EryPharm SAS BiotechnologyHealth Technology Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024. | Chief Executive Officer | - | - |
Career history of Daniel Marini
Former positions of Daniel Marini
| Companies | Position | Start | End |
|---|---|---|---|
Assala Energy UK Ltd.
 Assala Energy UK Ltd. MiscellaneousMiscellaneous Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
| Grande Côte Operations SA | Chief Executive Officer | - | - |
Statistics
International
| Canada | 2 |
| Australia | 2 |
| United Kingdom | 2 |
Operational
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Non-Energy Minerals | 2 |
| Miscellaneous | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ROBEX RESOURCES INC. | Non-Energy Minerals |
| Private companies | 3 |
|---|---|
| Grande Côte Operations SA | |
Assala Energy UK Ltd.
Assala Energy UK Ltd. MiscellaneousMiscellaneous Assala Energy UK Ltd. operates as a holding company that engages in oil exploration and production. It operates five fields and has four interests in four non-operated fields. The company is headquartered in London, the United Kingdom. | Miscellaneous |
EryPharm SAS
EryPharm SAS BiotechnologyHealth Technology Part of Safi Biotherapeutics, Inc., EryPharm SAS is a biotech startup based in Paris, France. EryPharm is focused on the development of cultured red blood cells (CRBCs) technology, which was pioneered by the team in 2002. The French company aims to confirm the product's non-toxicity through clinical trials in 2022, followed by trials in 2023 to confirm the benefits of CRBCs. The go-to-market authorization is expected in 2028 at the latest. EryPharm SAS was founded in 2016 by Prof. Luc Douay's team, a spin-off from Sorbonne University. The CEO is Daniel Marini. EryPharm was acquired by Safi Biotherapeutics, Inc. on January 05, 2024. | Health Technology |
- Stock Market
- Insiders
- Daniel Marini
- Experience
